| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 189.8 | 203.4 | 185.9 |
| Other income | 13.0 | 7.2 | 8.8 |
| Total income | 202.8 | 210.6 | 194.8 |
| Profit before exceptional items & tax | 53.5 | 59.7 | 54.9 |
| Exceptional items | 0.0 | 0.1 | 0.0 |
| Profit before tax | 53.5 | 59.8 | 54.9 |
| Net profit | 38.6 | 45.3 | 40.4 |
| Operating margin | 26.4% | 28.4% | 28.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -4.50% |
|---|---|
| Net profit, quarter on quarter | -14.80% |
| Revenue, year on year | +2.10% |
| Operating profit, year on year | -12.10% |
| Operating profit, quarter on quarter | -22.90% |
BSE results filing, NSE: ADVENZYMES. Figures extracted from the filing.
Advanced Enzyme Technologies Ltd: key numbers
- Share price
- ₹291.15
- Market cap
- ₹3,260 Cr
- Revenue (annual)
- ₹745.8 Cr
- Net profit (annual)
- ₹168.7 Cr
- P/E (TTM)
- 19.6×Sector 50.4×
- Promoter holding
- 43.24%-0.02% QoQ
- FII holding
- 26.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Advanced Enzyme Technologies Ltd
All →Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies Ltd bought back 50,000 equity shares on September 25, 2026. This transaction was executed at an average price of ₹295.80 per share.
- Value
- ₹1.48 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies bought back 64,668 shares on September 24, 2026, at an average price of ₹298.0272 per share.
- Value
- ₹1.93 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies bought back 63,616 shares at an average price of ₹297.47. The total value of today's buyback transaction is ₹1.89 Crore.
- Value
- ₹1.89 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies Ltd repurchased 1,136 equity shares on September 22, 2026, at an average price of ₹295.90. This daily filing is for compliance.
- Value
- ₹0.03 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies bought back 50,000 equity shares on September 21, 2026, at an average price of ₹289.49 per share.
- Value
- ₹1.45 Cr
Advanced Enzyme Technologies Promoter Reclassification
Advanced Enzyme Technologies received requests from four promoter group members to reclassify as 'Public' shareholders. These requests are pending board consideration.